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Otitis media (OM) is considered a potentially severe disease due to the risk of complications.
Objective: To establish the annual incidence of intratemporal complications (ITC) resulting from 
OM and to prospectively assess patients for epidemiological and clinical factors.
Method: This prospective cohort study included patients admitted during one year at a university 
hospital diagnosed with intratemporal complications of OM. Patients were analyzed for age, gender, 
type of intratemporal complication, treatment, and clinical outcome. The overall incidence of com-
plications and the specific incidence rates of each type of complication were determined.
Results: 1,816 patients were diagnosed with OM; 592 (33%) had chronic OM; 1224 (67%) had acute 
OM. Fifteen patients were diagnosed with OM ITC, adding up to an annual incidence of 0.8%. 
Nineteen diagnoses of ITC were made in 15 patients. Seven (36.8%) patients were diagnosed with 
labyrinthine fistula, five (26.3%) with mastoiditis, four (21.1%) with peripheral facial palsy, and three 
(15.8%) with labyrinthitis.
Conclusion: The incidence of intratemporal complications remains significant when compared to 
the rates seen in developed countries. Chronic cholesteatomatous otitis media is the most frequent 
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INTRODUCTION
Otitis media (OM) is considered a potentially severe 
disease due to the risk of complications1, and should be 
faced as a dynamic infirmity that ranges from a self-limiting 
benign condition to a prolonged and often complicated 
disease. A number of factors impact the form of disease 
patients develop, such as age, local and systemic immu-
ne status, virulence of the causing agent, and previous 
treatments2.
The advent of antibiotics in the last century, more 
particularly in the 1940s, led to a dramatic decline in the 
incidence of complications from acute otitis media (AOM) 
and chronic otitis media (COM), and changed the prefe-
rences from surgical treatment to predominantly clinical 
management of the disease3,4.
A meeting of the World Health Organization (WHO) 
on health policies for chronic middle ear infections held 
in 1998 defined OM as an important and permanent pu-
blic health issue, specifically in less favored communities 
in developing and developed countries. The WHO also 
verified the scarcity of population data on the matter, and 
called countries to compile epidemiological information 
to determine the impact of OM and set the priorities for 
prevention and treatment of the condition5. Brazilian epi-
demiological data publications are scarce, and adapting 
foreign data to the country’s reality is imprecise and less 
than rigorously scientific.
This paper aims to establish the annual incidence 
of intratemporal complications associated with otitis me-
dia and to prospectively assess the involved patients by 
analyzing epidemiological and clinical factors.
METHOD
This longitudinal prospective cohort study included 
patients diagnosed with acute and chronic otitis media and 
subjects with intratemporal complications arising from OM 
seen at an emergency care unit, an outpatient ward, and 
a university hospital from February of 2010 to January of 
2011. Patients with complications were followed up while 
they were hospitalized and seen in an outpatient setting. 
Patients with intratemporal complications were analyzed 
for the following factors: age, gender, type of intratempo-
ral complication, treatment, imaging findings, degree of 
peripheral facial palsy (House-Brackmann score6), type and 
degree of hearing loss (during the course of infection and 
after treatment), and clinical outcome. Overall and specific 
complication incidence rates were calculated. Intratempo-
ral complications were defined as follows: labyrinthine 
fistula - erosion of the endochondral bone overlying the 
labyrinth (seen on CT scans or surgery) without perilymph 
leakage; mastoiditis - erythema, edema/collapsing edema 
(including subperiosteal abscess); peripheral facial 
palsy - as per the House-Brackmann score definition; 
labyrinthitis - worsened hearing thresholds (reported by 
patient) verified by audiometry (drop in bone conduction) 
and followed by vestibular signs and symptoms. Patients 
with uncomplicated otitis had the following data analyzed: 
age, gender, otological diagnosis (AOM or COM). This 
study was approved by the institution’s Research Ethics 
Committee and given permit 0081/10.
RESULTS
In the twelve months covered by the study, 1.816 
patients were diagnosed with OM. Eight hundred and 
seventy-three (48%) were males and 943 (52%) females. 
The subjects had a mean age of 31 years (0-99 years). 
COM was diagnosed in 592 (33%) patients, while AOM was 
seen in 1224 (67%). A ratio of 2:1 was observed between 
AOM and COM.
Fifteen of the 1816 patients included in the study 
had intratemporal complications associated with otitis 
media, yielding an annual incidence rate of 0.8%. Nine 
(60%) of the 15 subjects were females and six (40%) were 
males. Chronic cholesteatomatous otitis media (CCOM) 
was diagnosed in 11 (74%) patients, AOM in three (20%), 
and non-cholesteatomatous chronic otitis media (NCCOM) 
in one (6%) subject. Mean age was 52 years (26-78 years).
Two of the fifteen individuals with intratemporal 
complications had two concurrent complications and one 
subject had three concurrent complications, adding up to 
19 diagnosed cases of ITC. The incidence of each compli-
cation is listed in Table 1. One patient had an associated 
intracranial complication (sigmoid sinus thrombosis). All 
patients were given intravenous antibiotics and steroids 
while hospitalized.
Table 1. Intratemporal complications of 15 patients in a total of 
19 diagnosed complications (two patients had two concurrent 
complications and one had three concurrent complications).
Intratemporal complication n %
Labyrinthine fistula 7 36.8%
Mastoiditis 5 26.3%
Peripheral facial palsy 4 21.1%
Labyrinthitis 3 15.8%
Total 19 100.0%
The distribution of the otological diagnoses of the 
19 complications can be seen on Table 2.
Canal wall down mastoidectomy was performed in 
10 (65%) patients; seven (47%) had undergone mastoidec-
tomy previously and four (57%) had been submitted to 
more than one mastoidectomy procedure. These patients 
had been diagnosed with CCOM. The approaches are sho-
wn in Table 3. Comorbidities were present in nine (60%) 
patients. The more prevalent were systemic hypertension 
(SH) and diabetes mellitus (DM).
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The signs and symptoms occurred prior to compli-
cation for each diagnosis are listed on Table 4.
Labyrinthine fistula
Seven patients were diagnosed with labyrinthine 
fistula, four (57%) males and three (43%) females. This 
complication had an annual incidence of 0.38%. Patient 
mean age was 59 years, with ages ranging from 44 to 78. 
Six (86%) patients were diagnosed with CCOM and one 
(14%) subject had NCCOM. Six (86%) patients had the 
disease for over five years. Table 5 contains a summary 
of the prevalences of signs and symptoms. Hypacusis and 
tinnitus were seen in all patients.
The nystagmus seen in two (29%) patients was 
triggered by intense sounds or pressure changes in the 
ear canal. Observed clinical manifestations, confirmation 
temporal bone CT scans, and intraoperative findings 
suggested the diagnosis of labyrinthine fistula. CT scans 
showed lateral semicircular canal (SCC) erosion in all 
patients in association with imaging findings consistent 
with CCOM (Figure 1).
Surgery was the treatment of choice for all patients, 
and five (84%) subjects underwent canal wall down mastoi-
dectomy. One patient had associated labyrinthitis. Patients 
were hospitalized for a mean of six days (3-21 days).
A female patient aged 59 years without history of 
chronic effusion complained of hypacusis and intense 
left ear tinnitus associated with vertigo lasting for four 
weeks. Otoscopic examination revealed her eardrum was 
retracted. She was being treated for diabetes mellitus and 
had undergone chemotherapy for lymphoma for 11 years. 
Temporal bone CT scans revealed a tumor with rounded 
edges occupying the antrum with lateral semicircular ca-
nal erosion. The patient was referred to surgery, as she 
was suspected to have CCOM. During surgery a tumor 
of fibroelastic consistency was seen in the antrum, along 
with adjacent mucosal inflammation. A biopsy was done 
and the pathologist’s report read chronic inflammatory 
Table 2. Distribution of complication diagnosis (n = 19).
Labyrinthine fistula (n = 7) Mastoiditis (n = 5) Peripheral facial palsy (n = 4) Labyrinthitis (n = 3) Total (n = 19)
n % n % n % n % n %
AOM - - 2 40.0% 2 50.0% 2 66.7% 6 31.6%
NCCOM 1 14.3% - - - - 1 33.3% 2 10.5%
CCOM 6 85.7% 3 60.0% 2 50.0% - - 11 57.9%
Total 7 100.0% 5 100.0% 4 100.0% 3 100.0% 19 100.0%
AOM: Acute otitis media; NCCOM: Non-cholesteatomatous chronic otitis media; CCOM: Chronic cholesteatomatous otitis media.
Table 3. Treatments offered to patients with complications 
(antibiotics and steroids were prescribed to all patients).
Treatment n %
Canal wall down mastoidectomy 10 66.7%
Closed mastoidectomy 2 13.3%
Retroauricular drainage 1 6.7%
Ventilation tube 1 6.7%
Conservative 1 6.7%
Total 15 100.0%
Table 4. Incidence of signs and symptoms preceding complications (%), for each diagnosis.
AOM (n = 3) NCCOM (n = 1) CCOM (n = 11) Total (n = 15)
n % n % n % n %
Otorrhea 3 100.0% - - 11 100.0% 14 93.3%
Hypacusis 3 100.0% 1 25.0% 9 81.8% 13 86.7%
Tinnitus 2 66.7% 1 25.0% 8 72.7% 11 73.3%
Otalgia 3 100.0% 1 25.0% 4 36.4% 8 53.3%
Vertigo 1 33.3% 1 25.0% 5 45.5% 7 46.7%
Nausea/vomiting 1 33.3% - 0.0% 2 18.2% 3 20.0%
Nystagmus 1 33.3% - 0.0% 2 18.2% 3 20.0%
AOM: Acute otitis media; NCCOM: Non-cholesteatomatous chronic otitis media; CCOM: Chronic cholesteatomatous otitis media.
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process. Immunohistochemistry was performed on the 
surgical specimen and the patient was diagnosed with an 
inflammatory myofibroblastic tumor. The patient was star-
ted on steroids and her symptoms and hearing thresholds 
improved significantly.
Preoperative audiometry revealed all subjects had 
mixed hearing loss, which was moderate in 43% (3/7) 
of the cases, severe in 43% (3/7), and mild in 14% (1/7). 
Postoperative audiometry showed persisting mixed hearing 
loss. Two (27%) patients improved their tone thresholds 
by a mean of 20 dB at 500, 1000, and 2000 Hz, while one 
(14%) subject had his thresholds worsened by 15 dB at 
the frequencies mentioned above.
Mastoiditis
Five patients were diagnosed with mastoiditis, two 
males and three females. They had a mean age of 44 years 
(26-66 years). The annual incidence of mastoiditis was 
0.27%. Three (60%) patients were diagnosed with CCOM 
and two (40%) with AOM. All patients with CCOM had 
diagnosed disease for at least five years. The time between 
the onset of symptoms and the patients looking for me-
dical care ranged between five and 33 days (mean = 25).
The encountered signs and symptoms and their 
incidence rates are shown on Table 6. Otalgia and otor-
rhea were seen in the five (100%) patients and tinnitus 
in three (60%).
Canal wall down mastoidectomy was offered to 
two (40%) patients, closed mastoidectomy to one (20%), 
retroauricular drainage to one (20%), and conservative 
treatment (antibiotics) to one (20%) subject.
One patient (20%) had associated intratemporal 
complications after the start of treatment with antibiotics 
for mastoiditis and developed peripheral facial palsy (PFP) 
and labyrinthitis. He underwent tympanocentesis and had 
a ventilation tube inserted. During hospitalization the 
patient improved from the symptoms and was referred 
to a closed mastoidectomy. The patient was hospitalized 
for 32 days and after intense investigation was diagnosed 
with Wegener’s granulomatosis (WG). The subject was 
started on cyclophosphamide and steroids, and improved 
completely from PFP and otorrhea.
Another patient had associated intracranial compli-
cation. The subject had been treated for AOM for 30 days 
when she came to our service complaining of ear pain 
and otorrhea. Contrast-enhanced CT scans of the temporal 
bones revealed opacified mastoid air cells and sigmoid 
sinus thrombosis. Magnetic resonance angiography scans 
confirmed the diagnosis. The patient was seen by the 
neurology and ophthalmology teams (to rule out otitic 
hydrocephalus), but she did not have signs of intracranial 
hypertension and her ocular fundus exam was normal. 
She was given broad spectrum antibiotics (ceftriaxone and 
clindamycin) associated with steroids, and evolved satis-
factorily. The patient was in hospital for seven days and 
was discharged on a 21-day course of cefuroxime axetil.
Two (40%) patients had systemic hypertension. 
The patients were hospitalized for a mean of 12 days 
(4-32 days).
Peripheral facial palsy
Three (75%) of the four individuals diagnosed with 
PFP were females. Subject mean age was 46 years, ranging 
from 26 to 64. The annual incidence of PFP was 0.22%. 
Two (50%) patients were diagnosed with CCOM and two 
(50%) with AOM. Patients with AOM endured symptoms 
for a mean of 30 days before they came to our service. Sub-
jects with CCOM waited for 10 days before seeking help.
One patient with mastoiditis developed grade IV 
PFP (House-Brackmann) and labyrinthitis. This patient 
was diagnosed with Wegener’s granulomatosis based on 
a positive c-ANCA test, but evolved satisfactorily with 
complete remission from PFP and proper management 
of the infection after specific treatment was initiated (as 
previously described). Another patient also had PFP and 
labyrinthitis. She had been started on antibiotics 30 days 
before for AOM and evolved well for two weeks, when 
hypacusis, tinnitus, and vertigo associated with PFP set 
in. The patient was on insulin for diabetes (right-eye 
amaurosis due to diabetic retinopathy) and was being 
Figure 1. Left-side temporal bone CT scan, axial cross-section, sho-
wing blurred antrum and erosion of the lateral semicircular canal.
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treated for hypothyroidism. She had grade IV PFP 
(House-Brackmann) and audiometry indicated severe 
mixed hearing loss. The patient was hospitalized, her 
antibiotics changed, steroid therapy was strictly managed 
and glucose levels controlled, and a myringotomy was 
performed with ventilation tube insertion. The patient was 
hospitalized for 10 days. When the patient was stabilized, 
she was discharged on decreasing dosages of steroids. 
Three months into follow-up the patient presented sig-
nificant regression from PFP (grade II), reported impro-
vement from tinnitus and vertigo, and her audiometry 
revealed moderate mixed hearing loss.
Three (75%) patients had grade IV and one (25%) 
had grade III PFP (House-Brackmann). Two (50%) subjects 
had other associated complications, a case of mastoiditis 
and another of labyrinthitis. Mean hospital stay length was 
13 days, and ranged from two to 32 days. Two individuals 
had canal wall down mastoidectomy procedures, one had 
a closed mastoidectomy, and one a myringotomy with 
ventilation tube insertion. Three patients evolved favorably 
from PFP, as seen on Table 7.
Labyrinthitis
There were no cases of isolated labyrinthitis. Three 
patients had labyrinthitis, adding up to an annual incidence 
of 0.1%. All had associated complications, as shown on 
Table 8. Hypacusis, tinnitus and vertigo were universally 
present and nystagmus was observed in two cases.
The three patients mentioned above took steroids 
for four weeks in decreasing dosages. Two months after 
treatment the patients reported complete improvement 
from vertigo and tinnitus and partial improvement from 
hypacusis. Audiometry tests showed improvements of 10 
to 20 dB at 500-1000 and 2000 Hz and residual mixed 
hearing loss.
DISCUSSION
This study found an annual incidence rate of intra-
temporal complications from OM of 0.8%, as also seen in 
other studies carried out in developing countries such as 
Thailand7, Turkey8, and Taiwan9, in which rates of 0.45%, 
1.35% and 3% were respectively reported. The apparently 
insignificant reported rates gain weight as they are com-
pared to the incidences seen in developed countries. For 
example, a study done in Finland10 reported an incidence 
of complications of 0.004%. We believe that troubled 
access to the public health care system, precarious servi-
ce, and lack of education promote the continuity of this 
situation, as discussed by other authors11,12.
COM was the most prevalent diagnosis, CCOM in 
particular, as it accounted for 74% of the complications. 
Although our sample featured a small number of patients 
(n = 15), this pattern was also seen in studies with larger 
cohorts7,8.
Three (20%) individuals had two or more intratem-
poral complications, and one patient had an associated 
intracranial complication (sigmoid sinus thrombosis). 
Concurrent complications have been abundantly reported 
in the literature7,8,11,13, stressing the need to meticulously 
investigate patients with complications for associated 
complications.
The signs and symptoms presented by patients 
with complications (Table 4) were divided between 
Table 7. Data from patients with PFP.
Age Comorbidity Diagnosis PFP grade (before) Treatment PFP grade (after)
26 None CCOM IV Canal wall down mastoidectomy III
31 * AOM IV Closed mastoidectomy I
63 DM; Hypothyroidism AOM IV Myringotomy + VT II
64 DM CCOM III Canal wall down mastoidectomy III
* Patient diagnosed with Wegener’s granulomatosis as a baseline condition; AOM: Acute otitis media; CCOM: Chronic cholesteatomatous otitis 
media; PFP: Peripheral facial palsy; DM: Diabetes mellitus; VT: Ventilation tube.
Table 8. Data from patients with labyrinthitis.
Age Comorbidity Diagnosis Audiometry (before) Associated complication Treatment Audiometry (after)
31 * AOM Severe mixed hearing loss Mastoiditis; PFP Closed mastoidectomy
Moderate mixed 
hearing loss
59 DM# NCCOM Severe mixed hearing loss Labyrinthine fistula Closed mastoidectomy
Moderate mixed 
hearing loss
63 DM; hypothyroidism AOM Moderate mixed hearing loss PFP Myringotomy and VT
Moderate mixed 
hearing loss
* Patient diagnosed with Wegener’s granulomatosis as a baseline condition; # Patient had history of lymphoma; AOM: Acute otitis media; NCCOM: 
Non-cholesteatomatous chronic otitis media; PFP: Peripheral facial palsy; DM: Diabetes mellitus; VT: Ventilation tube.
146
Brazilian Journal of otorhinolaryngology 79 (2) March/april 2013
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
subjects with complications stemmed from AOM and in-
dividuals with complications arising from COM (NCCOM 
and CCOM), as they are significantly different from each 
other. When looking at patients with AOM, we found that 
otalgia was present on 100% of the patients. By their turn, 
only 33% of the patients with COM had otalgia. The signs 
and symptoms of patients with complications from COM 
are typically nonspecific9, such as hypacusis and tinnitus, 
seen in 84% and 75% of these subjects respectively. They 
are also older and have associated comorbidities. Early 
diagnosis and complication prevention require careful 
patient examination.
Labyrinthine fistula
Labyrinthine fistula was the most frequently seen 
intratemporal complication (37%), with an annual inciden-
ce of 0.38%. It is defined as erosion of the endochondral 
bone overlying the labyrinth without perilymph leakage 
(unlike perilymphatic fistulae), and still is one of the most 
common complications in CCOM8. The incidence of this 
complication is thought to be underestimated. Studies on 
the complications of otitis media do not include all cases 
of labyrinthine fistula, as it does not produce significant 
symptoms and is detected only during surgery12.
Many authors do not include labyrinthine fistula in 
the differential diagnosis of intratemporal complications, 
as it usually does not produce exuberant clinical manifes-
tations and its symptoms are nonspecific. Considering this 
study’s most commonly seen signs and symptoms minus 
labyrinthine fistulae, otalgia, a symptom that certainly 
draws more attention from physicians as a sign of possi-
ble complications, would move up from fourth to second 
position, with an incidence of 75%, behind only otorrhea, 
seen in all cases. However, we believe labyrinthine fistula 
should be included, as it is a condition in which the la-
byrinth is exposed by the disease, consequently leaving 
vestibular function and hearing more vulnerable.
Although no intracranial complications from la-
byrinthine fistulae were seen in our study, they may occur 
from the communication between the labyrinth and the 
subarachnoid space, with meningitis being the most fre-
quently reported complication7-9. Meningitis may prevent 
the occurrence of other complications, intracranial ones 
in particular, when treated in time. The data gathered in 
this study serves as warning to the scientific community 
and ENTs in particular of the importance of identifying 
and treating labyrinthine fistulae before they evolve to 
perilymphatic fistulae.
Eighty-six percent (6/7) of the patients had CCOM, 
and in all cases the disease had been diagnosed for over 
five years and for over ten years in 72% (5/7) of the 
subjects, characterizing a pattern of slow insidious de-
velopment. It is hard to define when the cholesteatoma 
appeared, but using the date of disease manifestation, 
usually in the form of ear effusion, reported by the patient 
as a reference, one may infer that the disease had been 
around for even longer. The resorption of the ear capsu-
le is believed to be an insidious process (as previously 
mentioned), driven by inflammatory mediators activated 
on the matrix of the cholesteatoma or by pressure applied 
by the cholesteatoma14.
The erosion of the bone layer protecting the la-
byrinth allows pressure changes to be transmitted to 
the underlying endosteum, perilymph, and the adjacent 
endolymphatic compartment, thus evoking vestibular and 
even auditory symptoms. Only 29% (2/7) of the patients 
with labyrinthine fistula had nystagmus induced by pres-
sure changes in the ear canal (Hennebert sign) and intense 
noise (Tullio phenomenon). The literature reports slightly 
higher incidence rates, indicating that 32% to 50% of the 
patients tested positive for fistula will have it found during 
exploratory surgery14. Although the presence of sensori-
neural hearing loss, vertigo, and positive test for fistula 
suggest labyrinthine fistula, the absence of these findings 
does not necessarily mean the ear capsule is intact. The-
refore, it is prudent to consider fistula in the examination 
of all patients to undergo surgery.
In our study, the lateral semicircular canal was in-
volved in 100% of the individuals. Given its location close 
to the antrum, it is the most commonly involved portion of 
the labyrinth and, as reported by other authors, it accounts 
for approximately 90% of the cases12,14.
Eighty-six percent (6/7) of the patients had CCOM 
and underwent canal wall down mastoidectomy. Closed 
mastoidectomy was offered to one individual with NCCOM. 
Four patients (58%) had previously undergone mastoidec-
tomy. Labyrinthine erosion was observed in all cases. The 
cholesteatoma matrix was removed in two cases, when a 
safe cleavage plane was found.
Surgical approaches have been broadly discussed in 
the literature. Some authors believe the best procedure is 
canal wall down mastoidectomy, removing the choleste-
atoma and keeping the fistula covered by the matrix and 
moving it out into the cavity15,16. These authors believe 
that the complete removal of the matrix increases the risk 
of sensorineural hearing loss. The advocates of the clo-
sed approach claim it reduces the potential risk of bone 
erosion progression and infectious complications such as 
labyrinthitis. However, revision surgery is needed17,18. Canal 
wall down mastoidectomy (removing the cholesteatoma 
matrix whenever possible) was performed on all patients 
in our study because of the socio-economic characteristics 
of the population seen in our practice, the significant ex-
tension of the cholesteatomas at the time of surgery, and 
the difficulty scheduling revision surgery19.
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Mastoiditis
Described classically as the most frequent complica-
tion of otitis media, mastoiditis ranked second in our study, 
accounting for 28% of the diagnosed complications. This 
happened because labyrinthine fistulae were included in 
the differential diagnosis of intratemporal complications.
The annual incidence of mastoiditis seen in this 
study was 0.27%. Despite its declining incidence rates, 
mastoiditis is still very much a part of our reality. In deve-
loping countries, mastoiditis and other complications are 
still the most common cause of death for COM20.
The most frequently seen signs and symptoms were 
otalgia and otorrhea, observed in 100% of the patients. 
Mastoiditis needs to be correctly defined so it can be 
properly treated. In general terms, mastoiditis has been 
defined as mucosal thickening or mastoid cavity effusion. 
It occurs frequently in cases of AOM and COM and may 
be seen routinely in temporal bone CT scans. It is not a 
very significant clinical entity. However, clinical mastoi-
ditis - the entity described in this study - accompanied 
by erythema, edema, and at times by collapsing edema 
characterizing subperiosteal abscess, is a different story12. 
Meticulous investigation is required in these cases in or-
der to determine the most adequate course of treatment. 
Although diagnosis is imminently clinical, temporal bone 
CT scans, preferably contrast-enhanced, play an important 
role in planning therapy and ruling out other possible 
complications.
Although each type of complication arising from OM 
has a specific therapy, we believe certain treatment prin-
ciples can be generalized. First, one must define whether 
the patient has AOM or COM. Practically all cases of com-
plication from AOM evolve well with proper antibiotics and 
myringotomy with or without ventilation tube insertion. 
When complications stem from COM, broad spectrum an-
tibiotics effective against anaerobic and aerobic organisms 
are required, along with some form of mastoidectomy in 
most cases12. Canal wall down mastoidectomy was of-
fered to all three patients with mastoiditis diagnosed with 
CCOM. One of these patients had an aerated cheekbone 
and developed an abscess in the zygomatic process. The 
incision was planned to include the area of the abscess, as 
recommended in the literature14. After draining the abscess, 
the mastoidectomy was performed and the cholesteatoma 
removed the usual way.
The two cases of AOM-associated mastoiditis had 
complications, two intratemporal (PFP and labyrinthitis) 
and one intracranial (sigmoid sinus thrombosis). Both had 
otalgia and otorrhea and had taken oral antibiotics, but 
attained only partial resolution of symptoms. They sought 
our service 30 days after the onset of clinical manifesta-
tions with worsening symptoms. These cases show how 
the timing of the infection is strongly suggestive of mas-
toiditis. Marked otalgia or purulent otorrhea persist for 
two or more weeks, or symptoms recur after a period of 
apparent clinical improvement4,12.
The patient with sigmoid sinus thrombosis from 
AOM improved clinically with intravenous antibiotics 
administered in the hospital and was discharged on oral 
antibiotics for another three weeks. This case should 
serve as a warning to ENTs for the possibility of sigmoid 
sinus thrombosis without clinical manifestations and the 
benign progression of this condition. Because of these 
characteristics, the treatment of sigmoid sinus thrombosis 
has been discussed to form a trend towards more con-
servative therapies13,21, i.e., not approaching the sigmoid 
sinus directly and treating the baseline infectious disease 
effectively.
Peripheral facial palsy
Two of the patients with PFP were diagnosed with 
AOM and two with CCOM. In this study, the annual inci-
dence of PFP as an OM complication was 0.22%. Although 
seemingly insignificant, it is similar to the incidence rates 
seen in the pre-antibiotics era of 0.5-0.7%22,23. Current in-
cidence in developing countries revolves around 0.005%, 
according to a study carried out in Denmark24.
Peripheral facial palsy (PFP) may result from AOM 
and COM. Nerve insult usually occurs from congenital 
dehiscence of the facial nerve canal or by bone erosion 
caused by granulation tissue or cholesteatoma, which al-
low inflammatory mediators to compromise nerve function 
through a process known as suppurative neuropraxia12,14. 
Different theories have been proposed for PFP associated 
with AOM. Because of its shorter course of progression, it 
is believed that bone erosion and compressive phenom-
ena are less likely, and some authors believe that nerve 
injury occurs by the congestion of small vessels triggered 
by inflammatory processes, resulting in neural ischemia25.
The two patients with AOM had associated intratem-
poral complications, namely labyrinthitis and mastoiditis. 
Hydén et al. 26 described seven cases of concurrent PFP 
and labyrinthitis in AOM patients, and postulated that the 
invasion of toxins or infectious agents, probably through 
the round window membrane, was accompanied by in-
flammatory nerve injury. Other authors have described 
strong correlations between AOM and development of 
PFP and labyrinthitis10.
The patient with Wegener’s granulomatosis (WG) 
spent 32 days in hospital before being diagnosed. Vari-
ous authors have written about the importance of ruling 
out WG, a rare condition that may be present particu-
larly in cases not evolving to satisfaction despite proper 
treatment27-29.
The initial conduct in the two cases of PFP from 
AOM was to perform a myringotomy with ventilation tube 
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insertion (in addition to antibiotics and steroids). One 
of them did not evolve well (patient with WG) and was 
referred to closed mastoidectomy. Both improved satis-
factorily from PFP as described in the results. The patients 
diagnosed with CCOM had grade III and grade IV PFP and 
underwent canal wall down mastoidectomy. The injury 
was located in the tympanic segment in one case and 
in the transition of the tympanic to the mastoid (second 
knee) segment in the other. Six months into follow-up the 
patient with grade IV PFP moved down to grade III and 
the other remained with grade III PFP.
PFP prognosis varies whether the patient has AOM 
or CCOM. When PFP is caused by AOM, proper antibiot-
ics along with myringotomy to drain the purulent material 
and reduce bacteria counts lead to good nerve function 
recovery in most cases. On the other hand, when the 
cause is COM (with or without cholesteatoma), surgery is 
the treatment of choice. The infection around the nerve 
needs to be removed and function recovery is uncertain12, 
as seen in our cases.
Labyrinthitis
There were three cases of serous labyrinthitis (all 
described previously) followed by other intratemporal 
complications, namely labyrinthine fistula, mastoiditis, 
and PFP. Complaints of hypacusis, tinnitus, and vertigo 
were present in all patients, along with moderate to severe 
mixed hearing loss. It was the least frequent complication 
seen in the study, with an annual incidence rate of 0.1%.
Sensorineural hearing loss and vestibular disorders 
secondary to penetration of toxins or bacteria in the in-
ner ear structures still challenge ENTs30. Labyrinthitis is 
categorized as suppurative or serous. The first occurs 
due to invasion of the labyrinth by microorganisms (usu-
ally bacteria), introducing cochlear and vestibular injury 
and usually resulting in permanent severe or profound 
hearing loss, which was not seen in our study. When 
labyrinthine damage is caused by toxic bacteria products 
or inflammatory particles, the condition is called serous 
labyrinthitis and auditory sequelae tend to be milder and 
non-permanent31, with patients usually being able to par-
tially recover their hearing thresholds after the infection 
subsides, as seen in our study.
The differentiation between serous and suppura-
tive labyrinthitis is done clinically, based on response to 
treatment and audiometric improvement seen in patients 
with serous labyrinthitis30. Suppurative labyrinthitis is less 
prevalent today. Its incidence is estimated to have been 
reduced sevenfold since the introduction of antibiotics31.
Although serous labyrinthitis has been reported as 
one of the most common complications in otitis media32, 
only three subjects had it in our study. It has been assumed 
that many patients with serous labyrinthitis associated with 
OM respond well to conventional therapy and elective ear 
surgery to treat the baseline disease and, consequently, 
diagnosis is often missed.
Insults to the labyrinth may occur in many differ-
ent ways. Inflammatory processes of the meninges or the 
cerebrospinal fluid may travel to the inner ear (labyrinth) 
through the cochlear aqueduct or the internal acoustic 
canal (IAC). Ten percent of the patients with bacterial 
meningitis have labyrinthitis and profound hearing loss. 
Infection may also occur the other way around, i.e., it 
may start in the labyrinth and travel to the central nervous 
system. Other frequent dissemination pathways are seen 
when the focus of infection is in the middle ear and laby-
rinthine injury occurs through the round or oval window. 
We believe this was the mode of action of the labyrinthitis 
cases seen in this study. Bacteria from systemic infection 
may have reached the labyrinth transported by the blood-
stream, in a rare hematogenic dissemination pattern30,31.
CONCLUSION
The incidence of intratemporal complications is 
significant when compared to the rates seen in developed 
countries.
Chronic cholesteatomatous otitis media is the most 
common etiology of intratemporal complications.
Labyrinthine fistula is the most common intratem-
poral complication. Hypacusis and tinnitus were observed 
in all cases.
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